|
|
||||||||
Blocks p65 Phosphorylation and Thereby NF-
B-Mediated Transcription in TNF-Tolerant Cells1


,¶
* Institute of Clinical Chemistry and Pathobiochemistry, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany;
Department of Restorative Dentistry and Periodontology, Ludwig-Maximilians-University, Munich, Germany;
Department of Genetics, Biology, and Biochemistry, University of Turin, Turin, Italy;
Clinical Cooperation Group Inflammatory Lung Diseases, GSF-Forschungszentrum für Umwelt und Gesundheit-Institute of Inhalation Biology, Gauting, Germany; and
¶
Department of Microbiology and Immunology, University of Leicester, Leicester, United Kingdom
TNF is a major mediator of inflammation, immunity, and apoptosis. Pre-exposure to TNF reduces sensitivity to restimulation, a phenomenon known as tolerance, considered as protective in sepsis, but also as a paradigm for immunoparalysis. Earlier experiments in TNF-tolerant cells display inhibition of NF-
B-dependent IL-8 gene expression at the transcriptional level with potential involvement of C/EBP
. In this study, we have shown that a
B motive was sufficient to mediate transcriptional inhibition under TNF tolerance conditions in monocytic cells. Furthermore, in tolerant cells, TNF-induced NF-
B p65 phosphorylation was markedly decreased, which was accompanied by the formation of C/EBP
-p65 complexes. Remarkably, in C/EBP
/ cells incubated under the conditions of TNF tolerance, neither impairment of transcription nor inhibition of p65 phosphorylation was observed. Finally, we showed that C/EBP
overexpression reduced p65-mediated transactivation and that association of C/EBP
with p65 specifically prevented p65 phosphorylation. Our data demonstrate that C/EBP
is an essential signaling component for inhibition of NF-
B-mediated transcription in TNF-tolerant cells and suggest that this is caused by blockade of p65 phosphorylation. These results define a new molecular mechanism responsible for TNF tolerance in monocytic cells that may contribute to the unresponsiveness seen in patients with sepsis.
This article has been cited by other articles:
![]() |
S. Du, N. Hiramatsu, K. Hayakawa, A. Kasai, M. Okamura, T. Huang, J. Yao, M. Takeda, I. Araki, N. Sawada, et al. Suppression of NF-{kappa}B by Cyclosporin A and Tacrolimus (FK506) via Induction of the C/EBP Family: Implication for Unfolded Protein Response J. Immunol., June 1, 2009; 182(11): 7201 - 7211. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Neumann and M. Naumann Beyond I{kappa}Bs: alternative regulation of NF-{kappa}B activity FASEB J, September 1, 2007; 21(11): 2642 - 2654. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |